SCHEMBL19130232

SCHEMBL19130232

Cc1ccc([C@](C)(O)C(C)C)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.50
CYP19A1 P11511 1/20 0.41
KMT2A Q03164 5/20 0.39
MEN1 O00255 4/20 0.39
ALDH1A1 P00352 2/20 0.39
NPC1 O15118 1/20 0.38
MAPT P10636 1/20 0.38
RAB9A P51151 1/20 0.38
MLYCD O95822 1/20 0.38
ACHE P22303 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
HPGD P15428 1/20 0.36
LMNA P02545 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
HTT P42858 1/20 0.36
KIF11 P52732 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12238616 1.00 TSHR (0.50) TSHRCYP19A1KMT2AMEN1ALDH1A1
SCHEMBL17775052 0.90 MEN1 (0.40) TSHRKMT2AMEN1ALDH1A1TDP1
SCHEMBL12238630 0.83 MEN1 (0.36) TSHRKMT2AMEN1ALDH1A1TDP1
SCHEMBL18905278 0.81 MEN1 (0.34) TSHRKMT2AMEN1HPGDLMNA
SCHEMBL706386 0.79 APP (0.35) TSHRKMT2AMEN1HPGDLMNA
SCHEMBL22928607 0.79 MEN1 (0.37) TSHRCYP19A1KMT2AMEN1ALDH1A1
SCHEMBL12238642 0.79 KMT2A (0.60) TSHRCYP19A1KMT2AMEN1ALDH1A1
SCHEMBL3959121 0.78 CYP2D6 (0.47) KMT2AMEN1ALDH1A1MAPTCYP3A4
SCHEMBL12884227 0.78 CYP2D6 (0.47) KMT2AMEN1ALDH1A1MAPTCYP3A4
SCHEMBL28378957 0.78 TSHR (0.46) TSHRCYP19A1KMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170204036-A1 CHIRAL DIAMINE COMPOUNDS FOR THE PREPARATION OF CHIRAL ALCOHOLS AND CHIRAL AMINES UNIVERSITY COLLEGE DUBLIN (IE) 2017-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170204036-A1 CHIRAL DIAMINE COMPOUNDS FOR THE PREPARATION OF CHIRAL ALCOHOLS AND CHIRAL AMINES ADH1C, ADH1A, ADH5 TSHR 614/4885CYP19A1 1367/4885KMT2A 1833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.